Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.

Ma, L J

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. [electronic resource] - Kidney international May 2001 - 1899-910 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0085-2538

10.1046/j.1523-1755.2001.0590051899.x doi


Animals
Antihypertensive Agents--pharmacology
Base Sequence
Chromans--pharmacology
DNA Primers--genetics
Disease Models, Animal
Glomerulosclerosis, Focal Segmental--etiology
Hypoglycemic Agents--pharmacology
Insulin Resistance
Kidney--pathology
Lipids--blood
Macrophages--pathology
Male
Nephrectomy
Plasminogen Activator Inhibitor 1--genetics
RNA, Messenger--genetics
Rats
Rats, Sprague-Dawley
Receptors, Cytoplasmic and Nuclear--agonists
Thiazoles--pharmacology
Thiazolidinediones
Transcription Factors--agonists
Transforming Growth Factor beta--genetics
Troglitazone